Abeona Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Abeona Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $18.86. The average 1-year stock price forecast is 213.81% higher than the current stock price, while the lowest is $14 (+132.95%) and the highest is $28 (+365.89%).

Price Target: $18.86 (+213.81%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$14	$18.86	$17	$28
Change	+132.95%	+213.81%	+182.86%	+365.89%

Analyst Ratings

The average analyst rating for Abeona Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jan '26	Feb '26	Mar '26	May '26	Jul '26	Aug '26
Strong Buy	6	6	6	6	6	6
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $20	Buy	Reiterates	$20	+232.78%	Aug 24, 2026
Unknown Analyst Oppenheimer No rating	Oppenheimer	Buy Reiterates $21	Buy	Reiterates	$21	+249.42%	Aug 14, 2026
Unknown Analyst Jefferies No rating	Jefferies	Buy Maintains $17	Buy	Maintains	$17	+182.86%	May 14, 2026
James Molloy Alliance Global Partners	Alliance Global Partners	Buy Reiterates $20	Buy	Reiterates	$20	+232.78%	May 13, 2026
Stephen Willey Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $17	Buy	Maintains	$17	+182.86%	Mar 19, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

54.61M

from 5.82M

838.27%

from 5.82M

Revenue Next Year

119.21M

from 54.61M

118.31%

from 54.61M

EPS This Year

-0.74

from -1.24

EPS Next Year

-0.18

from -0.74

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.00M	1.41M	3.50M	-	5.82M	54.61M
Revenue Growth	-70.00%	-52.87%	147.53%	-	-	838.27%
Operating Income	-57.37M	-45.26M	-48.20M	-64.21M	-89.45M	-51.58M
Net Income	-84.94M	-39.70M	-54.19M	-63.73M	71.18M	-53.17M
EPS	-	-	-	-	-1.24	-0.74
Free Cash Flow	-62.58M	-19.73M	-18.89M	-37.88M	-55.60M	-44.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	79.0M
Avg	54.6M
Low	43.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	1,256.7%
Avg	838.3%
Low	638.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.50
Avg	-0.74
Low	-0.97

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-